Skip to content

Erdogan-Trinkaus Ipek

Reporting owner on Forms 3, 4 and 5, CIK 2047026.

Erdogan-Trinkaus Ipek reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ETON · Eton Pharmaceuticals, Inc.CIK 1710340officer (Chief Commercial Officer)12026-11-12

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ETON · Eton Pharmaceuticals, Inc.Common Stock2026-11-10M exercised+3,500$15.477,581Form 4
ETON · Eton Pharmaceuticals, Inc.Common Stock2026-11-10S sold-2,340$67.17875,241Form 4
ETON · Eton Pharmaceuticals, Inc.Common Stock2026-11-10S sold-1,160$67.87854,081Form 4
ETON · Eton Pharmaceuticals, Inc.Employee Stock Option, derivative2026-11-10M exercised-3,500$037,155Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001437749-26-036605 Eton Pharmaceuticals, Inc.2026-11-12